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ABSTRACT
Parafibromin, a component of the RNA polymerase
II-associated PAF1 complex, is a tumor suppressor
linked to hyperparathyroidism-jaw tumor syndrome
and sporadic parathyroid carcinoma. Parafibromin
induces cell cycle arrest by repressing cyclin
D1 via an unknown mechanism. Here, we show
that parafibromin interacts with the histone
methyltransferase, SUV39H1, and functions as
a transcriptional repressor. The central region
(128–227 amino acids) of parafibromin is important
for both the interaction with SUV39H1 and
transcriptional repression. Parafibromin associated
with the promoter and coding regions of cyclin D1
and was required for the recruitment of SUV39H1
and the induction of H3 K9 methylation but not
H3 K4 methylation. RNA interference analysis
showed that SUV39H1 was critical for cyclin D1
repression. These data suggest that parafibromin
plays an unexpected role as a repressor in
addition to its widely known activity associated
with transcriptional activation. Parafibromin as a
part of the PAF1 complex might downregulate
cyclin D1 expression by integrating repressive H3
K9 methylation during transcription.
INTRODUCTION
Paraﬁbromin is a 531-amino-acid tumor suppressor
protein encoded by the HRPT2 gene. It is the human
homolog of yeast Cdc73 within the polymerase-associated
factor 1 (PAF1) complex (1–3). Germ line and somatic
mutations of HRPT2 are found in HPT-JT (hyper-
parathyroidism-jaw tumor) and sporadic parathyroid
carcinoma patients (4–6).
The PAF1 complex, originally identiﬁed in yeast as
associated with RNA polymerase II, is comprised of
Paf1, Leo1, Ctr9, Rtf1 and Cdc73 (7,8). The yeast PAF1
(yPAF1) complex regulates transcription, including
transcriptional initiation and elongation (9,10), histone
H2B ubiquitination, histone H3 lysine (K) 4 and K79
methylation (11) and control of poly(A) length (12).
A subset of genes involved in metabolism and cell
cycle control is regulated by PAF1 (13,14). Drosophila
paraﬁbromin interacts with b-catenin to mediate a func-
tional link between Wnt signaling and gene expression
(15). However, the molecular mechanisms underlying the
tumor suppressor activities of paraﬁbromin remain
unclear.
Posttranslational modiﬁcations of histone tails within
nucleosomes, including acetylation, phosphorylation,
ubiquitination and methylation, modulate transcription
and chromatin structure (16,17). In general, histone H3
methylation on K4 is associated with transcriptional acti-
vation (18,19), while methylation of H3 K9 is associated
with transcriptional repression (20–22). Several histone
methyltransferases (HMTs) with evolutionarily conserved
SET domains, such as SUV39H1 and G9a, have H3
K9 methylation activity and are responsible for mono-,
di- and tri-methylation of H3 K9 (17). The biological
consequences diﬀer depending on the number of methyl
groups on histone residues.
The collapse of cell cycle control is common in human
cancer, where over-expression of cyclin D1 is one of the
most commonly observed alterations. Cyclin D1 was
identiﬁed critical in parathyroid tumors as indicated
by its alternative name, PRAD1 (parathyroid adeno-
matosis 1) oncogene (23). Interestingly, over-expression
of paraﬁbromin leads to repression of cyclin D1 and inhi-
bition of proliferation, thereby highlighting a potential
link of paraﬁbromin to cell cycle control through cyclin
D1 as a tumor suppressor (24–26). However, the detailed
molecular mechanism by which paraﬁbromin regulates
cyclin D1 is still unclear. Here, we show that paraﬁbromin
recruits SUV39H1 to the human cyclin D1 gene and
promotes histone H3 K9 methylation, suggesting
that paraﬁbromin, with SUV39H1, is a transcriptional
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proposes an unsuspected role for the PAF1 complex
beyond its classical role in active transcription.
MATERIALS AND METHODS
Plasmid construction
DNA constructs (pcDNA3-AU5-paraﬁbromin, pEGFP-
G9a, pBS-4xnH3 and the cyclin D1 promoter-luciferase
reporter construct) were kindly provided as mentioned
in the ‘Acknowledgements’ section. A DNA fragment
containing four tandem repeats of H3 tail (1–40) was
subcloned from pBS-4xnH3 into the GST vector by
PCR. Paraﬁbromin wild-type and deletion mutants were
generated by PCR and cloned into pM (Clontech),
pcDNA3.1 Myc/His, or pcDNA3-Flag vectors
(Invitrogen). Cloning was conﬁrmed by sequencing.
Cell culture and transfection
293T and HeLa cells were grown with DMEM containing
10% fetal bovine serum and 50U/ml penicillin/streptomy-
cin (WELGENE). Cells were transiently transfected
with Transfectin, according to the manufacturer’s
protocol (Bio-Rad). For RNA interference assays, cells
were transfected with small interfering RNAs (siRNAs)
against HRPT2 (Dhamacon or Invitrogen), G9a (Santa
Cruz), SUV39H1 (Santa Cruz) or control siRNA
(AccuTarget
TM Negative control siRNA, Bioneer) using
Lipofectamine 2000 (Invitrogen).
Luciferase assays
The 293T cells were transfected with the luciferase
reporters and DNA constructs and incubated for 24h
before harvest. Luciferase activity was measured according
to the manufacturer’s instructions (Promega). Each
transfection was performed in duplicate and repeated
three to ﬁve times.
Immunoprecipitation and immunoblotting
Transiently transfected 293T cells were harvested and
lysed in the lysis buﬀer [20mM Tris–HCl (pH 7.4),
150mM NaCl, 0.5 % NP-40, and inhibitors of proteases
and phosphatases]. Cell lysates were immunoprecipitated
with suitable antibodies along with protein-A (Amersham
Pharmacia Biotech.) or protein-G beads (Santa Cruz).
Immunoprecipitates were separated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS–PAGE),
transferred to a nitrocellulose membrane and immuno-
blotted with appropriate antibodies. Antibodies were
purchased from Bethyl Laboratories (paraﬁbromin, Paf1
and Leo1), Santa Cruz (Cyclin D1, GAPDH and GFP),
LabFrontier (a-tubulin), Roche [c-Myc (9E10)], Upstate
(G9a and SUV39H1) and Sigma [G9a and Flag (M2)].
Preparation of GST-4xnH3
GST-4xnH3 (amino acids 1–40) was expressed in
Escherichia coli by a standard protocol. Cells were dis-
rupted by sonication in phosphate-buﬀered saline (PBS)
(plus 1mM DTT, 1mM PMSF), and then Triton X-100
was added at a ﬁnal concentration of 1%. After centrifu-
gation, soluble fractions were used for incubation with
glutathione agarose beads (Sigma) for 30min at room
temperature. GST-H3 was eluted from the resin with
elution buﬀer [50mM Tris–HCl (pH 8.0) and 5mM
reduced glutathione]. The purity and the protein
concentrations were veriﬁed by Coomassie staining of
SDS–PAGE gels.
In vitro histone methyltransferase assay
Immunoprecipitates were incubated with 20mg of GST-
4xnH3 (amino acids 1–40) in HMTase buﬀer [50mM
Tris–HCl (pH 8.5), 20mM KCl, 10mM MgCl2 and
50mM S-adenosyl-L-methionine] for 1h at 30 C. Sample
buﬀer [2% SDS, 10% glycerol, 100mM DTT, 60mM Tris
(pH 6.8) and 0.001% bromophenol blue] was added to
stop the reaction. Proteins were separated by SDS–
PAGE and further analyzed by immunoblotting using
appropriate antibodies.
Quantitative real-time polymerase chain reaction analysis
Cultured HeLa cells were transfected with control,
HRPT2, G9a or SUV39H1 siRNAs for 24or 48h. Total
RNA was isolated using Trizol (Invitrogen), and comple-
mentary DNA (cDNA) synthesis was performed with the
Reverse Transcription System (Promega). Quantitative
real-time polymerase chain reaction (PCR) was performed
with speciﬁc primers for human cyclin D1 and GAPDH
using the KAPA
TM SYBR FAST qPCR KIT
(KAPABIOSYSTEMS) and Chromo4
TM real-time PCR
detector (Bio-Rad). Relative levels of mRNA were
normalized to the values of GAPDH mRNA for each
reaction. The following primers were used: cyclin D1
(#898 and #899) (50-CTGTGCTGCGAAGTGGAAA
CC-30 and 50-GTCCAGGTAGTTCATGGCCAGC-30),
HRPT2 (#512 and #513) (50-ACTGAACAGATTAG
GTC-30 and 50-ACATCTACCTCAGCATCC-30), SUV3
9H1 (#1191 and #1192) (50-GATATGACCTCTGCAT
CTTCCGC-30 and 50-GTACACGTCCTCCACGTAGT
CCAG-30), G9a (#1193 and #1194) (50-GTTTCCACCC
TCGGCAGTTG-30 and 50-CTGCATTTATGTTGGCT
CCAGC-30), GAPDH (#1189 and #1190) (50-TCAATG
GAAATCCCATCACCATC-30 and 50-CTTCTCATGGT
TCACACCCATGAC-30).
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed
according to the manufacturer’s protocol (Upstate
Biotechnology). Sonicated lysates were used for ChIP
with antibodies against paraﬁbromin (Bethyl Laboratory),
SUV39H1(Upstate), G9a (Abcam), dimethyl H3 K4
(Upstate), dimethyl H3 K9 (Abcam), trimethyl H3 K9
(Upstate) or normal serum as a control. Immunopre-
cipitated DNA and input DNA were analyzed by quanti-
tative real-time PCR using speciﬁc primers to cyclin D1:
promoter region (#704 and #705) (50-TGAAAATGAAAG
AAGATGCAGTCG-30 and 50-CTGTAGTCCGGTTTT
CATAGAAATGC-30), coding region (#738 and #739)
(50-GTCCTACTTCAAATGTGTGCAGAAGG-30 and
Nucleic AcidsResearch, 2010, Vol.38,No. 2 38350-CTCCCACGAAACGCTACTTCTAGC-30), 5kb
upstream region (#744 and #745) (50-CCCAGTTACTGT
CGTTATCTCTCATC-30 and 50-ATCCCTTTTGTAGC
ATCCCAAGAG-30).
RESULTS
Paraﬁbromin functions as a transcriptional repressor
We ﬁrst examined the transcriptional activity of
paraﬁbromin. Gal4-fused paraﬁbromin was expressed in
HEK293T cells along with a Gal4-tk luciferase reporter
that contains four Gal4-binding sites upstream of the
thymidine kinase (tk) promoter. Gal4-paraﬁbromin dose-
dependently repressed luciferase gene activity (Figure 1A).
trichostatin A (TSA), a general inhibitor of histone
deacetylases (HDAC), elevates general transcription
activity. However, paraﬁbromin was able to repress the
reporter activity irrespective of whether TSA was added
or not ( 6.5-fold in the presence and  4.3-fold in the
absence of TSA), suggesting that paraﬁbromin represses
genes by a mechanism largely independent of HDAC
(Figure 1B).
Paraﬁbromin speciﬁcally interacts with HMT
Complexes with paraﬁbromin show HMT activity that
targets H3 K4, which is implicated in transcriptional acti-
vation (2). However, in general, transcriptional repression
is associated with methylation of H3 K9. Therefore, we
tested whether paraﬁbromin induces H3 methylation
activity targeting K9 by ﬁrst examining the physical
association of paraﬁbromin and SUV39H1 or G9a, the
representative H3 K9 methyltransferases. Co-immuno-
precipitation experiments indicated that paraﬁbromin
could interact with both EGFP-SUV39H1 and
EGFP-G9a (Figure 2A). In addition, endogenous
paraﬁbromin interacted with Flag-SUV39H1 and
endogenous SUV39H1 in HeLa cells (Figure 2B and C).
Although we observed a strong interaction between
paraﬁbromin and GFP-G9a (Figure 2A), the interaction
between endogenous proteins was barely detected under
the same conditions as SUV39H1 (data not shown).
Taken together, our data indicate that paraﬁbromin
associated with at least SUV39H1 and has a potential to
integrate H3 K9 methylation for gene repression.
Given the association of paraﬁbromin with SUV39H1,
we tested whether the paraﬁbromin-containing complex
had HMT activity targeting H3 K9. Paraﬁbromin was
partially puriﬁed by immunoprecipitation using an anti-
paraﬁbromin antibody and subjected to an in vitro HMT
assay using four tandem repeats of amino acids 1–40
of H3 as a substrate. Modiﬁcations on diﬀerent residues
of H3 were then analyzed by an immunoblotting assay
with speciﬁc antibodies. The paraﬁbromin complex
immunoprecipitated from cell lysate directed H3
methylation on K9 as well as K4 (Figure 2D, lane 3). As
a control, IP without speciﬁc IgG showed no HMT
activity (lane 2). The substrate itself puriﬁed from
bacteria gave no signals (lane 1). Importantly,
paraﬁbromin-associated H3 methylation activity was
speciﬁc to K9 and K4 because H3 K36 signal was not
dependent on paraﬁbromin and seemed to be nonspeciﬁc
background. In fact, Rozenblatt-Rosen et al. (2) have
detected HMT activity associated with paraﬁbromin,
targeting H3 K9, which was much weaker than H3 K4
methylation in their experimental condition, although
it was not described further. Overall, our data indicate
that paraﬁbromin might function through SUV39H1,
and propose a combined role of paraﬁbromin,
SUV39H1 and H3 K9 methylation in regulating gene
transcription.
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Figure 1. Paraﬁbromin represses transcription. (A) Gal4-paraﬁbromin represses tk-driven luciferase reporter gene activity. The 293T cells were
transfected with diﬀerent amounts of Gal4DB-fused paraﬁbromin (0.1mg, 0.5mg) along with the 4xGal4-tk-luciferase reporter. Reporter gene
activities were normalized to protein concentration. (B) Transcriptional repression by paraﬁbromin is not aﬀected by an inhibitor of histone
deacetylase. The 293T cells were transfected with the Gal4-tk-luciferase reporter and GAL4-paraﬁbromin. TSA was added, as indicated, 24h
after transfection. Luciferase activities were measured 24h after TSA treatment.
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SUV39H1 interaction and repression activity
To identify the region of paraﬁbromin responsible
for the SUV39H1 interaction, we performed co-immuno-
precipitation experiments with a series of Flag-
paraﬁbromin derivatives and EGFP-SUV39H1 in 293T
cells. Paraﬁbromin WT and mutants lacking far-end
C-terminal regions (413X) and a mutant with only the
central region (128–413) retained strong interactions
with SUV39H1 (Figure 3A). The N-terminal half (227X)
maintained a weak interaction with SUV39H1, but a
larger deletion of the N-terminal region (N250)
completely disrupted the interaction with SUV39H1,
indicating that the central region of paraﬁbromin
(128–250) is important and the region of 128–227 is min-
imally necessary for the SUV39H1 interaction (Figure 3A
and C). Interestingly, 227X and N250 failed to interact
with the PAF1 complex (Paf1 or Leo1), while paraﬁbro-
mins encompassing 128–227 maintained the interaction
(Figure 3B and C), suggesting that paraﬁbromin interacts
with SUV39H1 directly independently of other
components of the PAF1 complex. Our domain analysis
narrowed down the interaction surface of paraﬁbromin
for Paf1/Leo1 to a region of 227–250 amino acids as
well (Figure 3C).
To further address whether the SUV39H1 interaction
domain is important for the repression of transcription,
we analyzed the ability of truncated forms of Gal4-
paraﬁbromin to repress transcription in 293T cells.
All constructs were expressed at a similar level
(Supplementary Figure S1). Paraﬁbromin mutants
lacking the SUV39H1 interaction domain failed to
repress reporter gene activity, but the interaction domain
(128–227) alone was suﬃcient to exert repression
(Figure 3D). The weak interaction on the small fragment
(128–227) seemed suﬃcient to support repression within
the transcription complex. Taken together, these data
suggest that the SUV39H1-binding region is important
for transcriptional repression by paraﬁbromin.
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Figure 2. Paraﬁbromin speciﬁcally associates with the H3 K9 histone methyltransferase, SUV39H1. (A) Paraﬁbromin associates with EGFP-
SUV39H1 and EGFP-G9a in vivo. The 293T cells were transiently transfected with EGFP-SUV39H1 or EGFP-G9a and Flag-paraﬁbromin. Cell
lysates were immunoprecipitated with anti-Flag antibody and then immunoblotted with anti-GFP (upper panel) or anti-Flag (lower panel)
antibodies, respectively. (B) Association of paraﬁbromin with SUV39H1. The 293T cells were transfected with control (lanes 1 and 3) or Flag-
SUV39H1 expressing construct (lanes 2 and 4). Flag-SUV39H1 immunoprecipitates were immunoblotted with anti-paraﬁbromin antibody. Asterisk
indicates immunoglobulin heavy chains. (C) Co-immunoprecipitation assay was used to detect interaction of endogenous paraﬁbromin with
SUV39H1 in HeLa cells. (D) Endogenous paraﬁbromin was immunoprecipitated and HMT activity associated with precipitates was directly
analyzed using GST-4xnH3 (amino acids 1–40). GST-4xnH3 consists of GST and four tandem repeats of amino acids 1–40 of H3. Paraﬁbromin
dependent histone modiﬁcation was analyzed by immunoblotting using H3 K9 dimethyl, H3 K9 trimethyl, H3 K36 dimethyl and paraﬁbromin
antibodies. Probing H3 K36 methylation showed only nonspeciﬁc background. Substrate used for in vitro HMT reaction was revealed by anti GST
antibody.
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Over-expression of paraﬁbromin decreases cyclin D1
expression, but the molecular mechanism is still unclear.
Paraﬁbromin-dependent genes, such as cyclin D1, could
be a target of SUV39H1-mediated transcriptional repres-
sion. We ﬁrst examined the transcriptional activity of
paraﬁbromin at the cyclin D1 promoter by a reporter
assay. As expected, paraﬁbromin repressed cyclin D1
promoter-driven luciferase activity (Figure 4A). We then
depleted paraﬁbromin by siRNA speciﬁcally targeting
HRPT2 in HeLa cells. This siRNA reduced the levels
of paraﬁbromin and other components of the PAF1
complex (Paf1 and Leo1) as well, consistent with other
reports (27,28), but increased cyclin D1 levels
(Figure 4B, left panel). Similarly, HeLa cells stably
expressing shRNA targeting a Paf1 subunit depleted
Paf1, paraﬁbromin and Leo1, and elevated cyclin D1
(Figure 4B, right panel). Thus, paraﬁbromin, as a compo-
nent of the PAF1 complex, downregulates the expression
of cyclin D1.
Paraﬁbromin mediates cyclin D1 repression
with SUV39H1
The direct role of SUV39H1 on cyclin D1 expression
was analyzed by treating cells with siRNAs to inhibit
the expression of SUV39H1 or G9a for comparison.
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Figure 3. SUV39H1 binds to the central region of paraﬁbromin, which is important for repression. (A) SUV39H1 binds to the central region of
paraﬁbromin. The 293T cells were transfected with EGFP-SUV39H1 with various Flag-tagged paraﬁbromin mutants. For interactions, cell lysates
were immunoprecipitated with anti-Flag antibody and immunoblotted with anti-GFP or Flag antibodies. (B) Paf1 and Leo1 bind to the central
region of paraﬁbromin. The 293T cells were transfected with various Flag-tagged paraﬁbromin mutants. For interactions, cell lysates were
immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Paf1, Leo1 or Flag antibodies. In (A) and (B), asterisks indicate the
immunoglobulin heavy chains. (C) Diagram of deletion mutants of paraﬁbromin and its interaction with SUV39H1 and PAF1 components. (D) The
SUV39H1-binding domain in paraﬁbromin is suﬃcient to repress transcription. The 293T cells were transfected with Gal4DB-fused paraﬁbromin
mutants along with the 4xGal4-tk-luciferse reporter. The values are averages from ﬁve independent experiments.
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their target HMTs (Figure 5A). Notably, depletion
of SUV39H1, but not G9a, signiﬁcantly increased the
RNA level of cyclin D1, as observed in paraﬁbromin-
knockdown cells (Figure 5B). Importantly, depletion
of both HMTs did not further aﬀect the cyclin
D1 level, indicating that SUV39H1, but not G9a, is
the functional component of cyclin D1 regulation.
Furthermore, although depletion of HRPT2 and
SUV39H1 increased the expression of cyclin D1 sepa-
rately, simultaneous depletion of both proteins did not
have an additive eﬀect on cyclin D1 level (Figure 5C).
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Figure 5. Paraﬁbromin and SUV39H1 contribute to the cyclin D1 repression. (A) Validation of SUV39H1 (left) and G9a (right) knockdown. HeLa
cells were transfected with SUV39H1, G9a siRNAs or control siRNA, and expression of SUV39H1 and G9a were checked by quantitative RT–PCR
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(C) Quantitative analysis of cyclin D1 mRNA obtained 1 day after treatment of siRNAs as indicated at the bottom. The PCR values were
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the expression of SUV39H1 or G9a (Supplementary
Figure S2). Thus, our data show that SUV39H1 and
HRPT2 function together at the protein level and contrib-
ute signiﬁcantly to the repression of cyclin D1, putatively
because of the recruitment of SUV39H1 via paraﬁbromin
and the subsequent methylation of H3 K9 onto the cyclin
D1 gene.
Next, we performed ChIP with primers probing the
upstream ( 5kb), promoter (–700 to –400bp), and
coding regions ( 1kb) of the cyclin D1 gene to investigate
whether the cyclin D1 regulation by paraﬁbromin and
SUV39H1 is accompanied by changes in chromatin
(Figure 6A). Anti-paraﬁbromin ChIP indicated that
paraﬁbromin was present at the promoter and coding
regions, but absent at about 5kb upstream from the
cyclin D1 transcription start site (Supplementary Figure
S3). The occupancy of paraﬁbromin at both regions
diminished signiﬁcantly upon paraﬁbromin depletion by
siRNA (Figure 6B, top panel). We then tested the possi-
bility that SUV39H1 was recruited to the cyclin D1
gene through the interaction with paraﬁbromin by
comparing its occupancy in the presence and absence of
paraﬁbromin. To do this, cross-linked chromatin
fragments from HeLa cells pretreated with control or
paraﬁbromin-siRNA were immunoprecipitated with
SUV39H1 antibody. ChIP with anti-SUV39H1 showed
that SUV39H1 associated in a broad region encompassing
cyclin D1 (Figure 6B, middle panel). However, this asso-
ciation was profoundly decreased in the paraﬁbromin
knockdown cells around the promoter and the coding
regions. Although the impact of G9a depletion on cyclin
D1 mRNA level was negligible (Figure 5B), G9a was
associated with the cyclin D1 gene in a paraﬁbromin-
dependent manner, as its occupancy was also largely
diminished by paraﬁbromin knockdown in the promoter
and coding regions (Figure 6B, bottom panel).
Importantly, the level of H3 K9 trimethylation,
predominantly enriched in the promoter region, was
greatly reduced in paraﬁbromin-knockdown cells (Figure
6C, top panel). Moreover, the level of H3 K9 dimeth-
ylation was also prominently aﬀected in the promoter
and coding regions but not in the upstream region
(Figure 6C, middle panel). However, histone H3 K4
dimethylation was not aﬀected by paraﬁbromin at all
(Figure 6C, bottom panel), similarly to the eﬀect of Ctr9
knockdown reported by others (27). These results suggest
that SUV39H1 (and G9a as well) was recruited to the
cyclin D1 promoter and coding regions via interactions
with paraﬁbromin to induce H3 K9 methylation
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Figure 6. Paraﬁbromin recruits SUV39H1 to promote H3 K9 methylation around cyclin D1 gene. (A) Cyclin D1 locus showing regions subjected to
ChIP analysis. (B, C) HeLa cells were treated with siRNA targeting HRPT2 or with an untargeted control siRNA for 24h. Cells were then analyzed
by ChIP using control antibody (rabbit IgG) and antibodies against indicated proteins or H3 modiﬁcations as described in ‘Materials and methods’
section. Immunoprecipitated DNA was analyzed in duplicates by quantitative RT–PCR to measure the relative recruitment of paraﬁbromin,
SUV39H1, or G9a (B) or the relative levels of H3K4 or H3K9 methylation along the cyclin D1 locus (C) ChIP with control IgG was subtracted
from all ChIP values (IP/Input, the percentage of ChIP). Data represent the percentage of ChIP signal normalized to the value of promoter region of
the control siRNA sample to compare the relative enrichment of signals along the region. (The ChIP value obtained by ampliﬁcation of promoter
region of the control siRNA sample was arbitrarily set to 1 in each panel.) Data represent the average of two or three independent experiments.
Error bars indicate the standard deviation between experiments.
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structure and downregulating cyclin D1 expression.
DISCUSSION
Paraﬁbromin recruits SUV39H1 (and G9a) to the
promoter and coding regions of cyclin D1 to regulate
its expression by integration of H3 K9 methylation.
Our study suggests a unique mechanism for transcrip-
tional repression by paraﬁbromin in addition to its role
in active transcription. In general, PAF1 components
associate with elongating RNA polymerases and
transcriptionally active genes. In contrast to other
typical repressors, paraﬁbromin, as a component of the
PAF1 complex, associates with actively transcribed
regions and downregulates their expression while tran-
scription is ongoing.
PAF1 is a transcription elongating complex
(9–12,27,29). Importantly, it couples transcription to
histone modiﬁcation by promoting H3 K4 and K79
methylation. In the current study, we found that the
paraﬁbromin subunit of PAF1 mediates H3 K9
methylation in the cyclin D1 gene more actively than K4
methylation. We propose that SUV39H1 tethered by
paraﬁbromin and subsequent methylation of H3 K9 help
maintain repressive chromatin structure to counteract
active transcription. In budding yeasts, where H3 K9
methylation is absent, H3 K36 methylation within
the body of actively transcribed genes couples
transcriptional elongation to histone deacetylation for
construction of repressive chromatin structure (30–32).
In higher eukaryotes, H3 K9 methylation and HP1g
(Heterochromatin Protein 1g) are unexpectedly associated
with active genes in a polymerase II-dependent manner,
yet it is not known why H3 K9 methylation is present at
actively transcribed genes (33). Similar to H3 K36
methylation in yeast, H3 K9 methylation may be
required to maintain repressive chromatin structure for
keeping transcription at submaximal levels. In this
regard, paraﬁbromin and Set2 are similar. Set2,
the HMT responsible for transcription elongation-
coupled H3 K36 methylation, also has repressor activity
when artiﬁcially tethered to a heterologous promoter,
indicating its role in the downregulation of gene transcrip-
tion (34).
In fact, loss of each component of PAF1 results in either
an increase or decrease of transcription (35), reﬂecting the
possibility that PAF1 has both positive (H3 K4/K79
methylation) and negative (H3 K9 methylation) eﬀects
on transcription. The sensitivity to positive and negative
regulation by PAF1 probably results from the molecular
environment such as interacting protein networks and
upstream signals. Cyclin D1 may be dominated by
PAF1’s negative eﬀect through H3 K9 methylation via
paraﬁbromin. Of note, Takeuchi independently reported
that the jumonji protein, Jmj, contributes to H3 K9
methylation by recruiting GLP (H3 K9 HMT) and G9a
to repress the cyclin D1 promoter (36). As in our study,
inactivation of GLP, but not of G9a, dramatically aﬀects
cyclin D1 expression, implying that GLP is critical while
G9a plays a supportive role. In both studies, H3 K9
methylation seems to be an important signature for
cyclin D1 regulation. Paraﬁbromin and the PAF1
complex repress the c-myc proto-oncogene as well (28).
If so, it will be of interest to determine whether H3 K9
methyltransferase activity is also involved in c-myc gene
regulation.
Paraﬁbromin functions as a tumor suppressor and
plays a pivotal role in HPT-JT and sporadic parathyroid
tumorigenesis. However, recently, paraﬁbromin was
reported to mediate nuclear transduction of Wnt signaling
by interacting with b-catenin, in striking contrast to its
role as a tumor suppressor (15). b-Catenin drives the
expression of proliferative genes, such as cyclin D1 and
c-myc. It is probable that paraﬁbromin/PAF1 may play a
dual role even in the same gene by alternating H3 K4/K79
(27,37) and H3 K9 methylation (this study). According to
our hypothesis, an activated Wnt signal in human cancers
could shift the balance toward H3 K4/K79 methylation
to drive the cell cycle. In this regard, it is noteworthy
that other core subunit, Paf1, is often ampliﬁed and
overexpressed in many cancers (6). As control of the cell
cycle is critical and widely disrupted in cancer, further
work on paraﬁbromin, the PAF1 complex, histone
methylation, and their integration with other regulatory
networks such as Wnt will clarify their precise role in
transcriptional regulation and cancer pathogenesis.
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